Main text
Tu Y, Wang L, Rong Y, Tam V, Yin T, Gao S, Singh R, Hu M. 2021. Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats. eLife 10:e58820. doi: 10.7554/eLife.58820.
Published 1 July 2021
Recently, we identified some calculation errors in the data reported in Table 1. The calculation errors arose when we calculated the average values and the standard deviations (SDs). The average values were presented in percentage units while the SDs remained in the original format (e.g., “0.423±0.2” was presented as “42.3 ± 0.2%”). We have checked the SDs with their corresponding average values and have now corrected the results so that the values are presented correctly. As well as correcting these calculation errors we have made several updates to the values listed in Appendix 2—table 5. The new tables are provided with this correction. The corrections did not change any of the conclusions of the manuscript. We sincerely apologize for the mistakes.
Table 1 after correction (corrected values highlighted for illustrative purposes in bold):
Table 1. Comparison of bililary secretion rates and recycle ratios of glucuronides following hepatic glucuronide infusion, hepatic aglycone infusion and small intestinal aglycone perfusion.
The rate of hepatic infusion was 20 nmol/hr and the rate of intestinal perfusion was 24 nmol/hr
| Dosing method | Hepatic glucuronide infusion | Hepatic aglycone infusion | Small intestine aglyconeperfusion |
|---|---|---|---|
| Infused compounds | Eze-4'-G | Ezetimibe (Eze) | Ezetimibe (Eze) |
| Won-7-G | Wongonin (Won) | Wongonin (Won) | |
| Ral-6-G | Raloxifene (Ral) | Raloxifene (Ral) | |
| Api-7-G | Apigenin (Api) | Apigenin (Api) | |
| Bai-7-G | Baicalein (Bai) | Baicalein (Bai) | |
| Measured compound | Bile secretion rate(nmol/hr) | ||
| Eze-4'-G | 19.31 ± 1.85 | 2.93 ± 0.41***,† | 21.94 ± 5.29 |
| Won-7-G | 16.30 ± 4.28 | 8.46 ± 3.93***,† | 17.90 ± 11.96 |
| Ral-6-G | 10.53 ± 1.51 | 3.91 ± 0.82*** | 4.00 ± 0.68 |
| Api-7-G | 10.64 ± 4.49 | 1.22 ± 0.76***,† | 11.32 ± 4.08 |
| Bai-7-G | 0.69 ± 0.29 | 0.09 ± 0.07***,† | ND† |
| Measured compound | Recycle ratio(%) | ||
| Eze-4'-G | 96.54 ± 9.23 | 14.65 ± 2.05***,† | 91.42±22.04 |
| Won-7-G | 81.5 ± 21.41 | 42.30 ± 20.00***,† | 74.58±49.83 |
| Ral-6-G | 52.64 ± 7.54 | 19.55 ± 4.10***,† | 16.67±2.83 |
| Api-7-G | 53.21 ± 22.44 | 6.10 ± 3.80***,† | 47.17±17.00 |
| Bai-7-G | 3.43 ± 1.46 | 0.45 ± 0.35***,† | ND† |
*Significant difference between hepatic glucuronide infusion and hepatic aglycone infusion, p<0.01
†Significant difference between hepatic aglycone infusion and small intestinal perfusion, p<0.01
‡Not determined due to below quantification limit.
Table 1 before correction was provided as reference (incorrect values highlighted for illustrative purposes in bold):
Table 1. Comparison of bililary secretion rates and liver recycling efficiency (%) of glucuronides following hepatic glucuronide infusion, hepatic aglycone infusion and small intestinal aglycone perfusion.
The rate of hepatic infusion was 20 nmol/hr and the rate of intestinal perfusion was 24 nmol/hr
| Dosing method | Hepatic glucuronide infusion | Hepatic aglycone infusion | Small intestine aglyconeperfusion |
|---|---|---|---|
| Infused compounds | Eze-4'-G | Ezetimibe (Eze) | Ezetimibe (Eze) |
| Won-7-G | Wongonin (Won) | Wongonin (Won) | |
| Ral-6-G | Raloxifene (Ral) | Raloxifene (Ral) | |
| Api-7-G | Apigenin (Api) | Apigenin (Api) | |
| Bai-7-G | Baicalein (Bai) | Baicalein (Bai) | |
| Measured compound | Bile secretion rate(nmol/hr) | ||
| Eze-4'-G | 19.31±1.85 | 2.93±0.41***,† | 21.94±5.29 |
| Won-7-G | 16.30±4.28 | 8.46±3.93***,† | 17.90±11.96 |
| Ral-6-G | 10.53±1.51 | 3.91±0.82*** | 4.00±0.68 |
| Api-7-G | 10.64±4.49 | 1.22±0.76***,† | 11.32±4.08 |
| Bai-7-G | 0.69±0.29 | 0.09±0.07***,† | ND† |
| Measured compound | LRE(%) | ||
| Eze-4'-G | 96.54±9.23 | 14.65±0.02***,† | 91.42±22.04 |
| Won-7-G | 81.5±21.41 | 42.30±0.20***,† | 74.58±49.83 |
| Ral-6-G | 52.64±7.54 | 19.55±0.04***,† | 16.67±2.83 |
| Api-7-G | 53.21±22.44 | 6.10±0.04***,† | 47.17±17.00 |
| Bai-7-G | 3.43±1.46 | 0.45±0.35***,† | ND‡ |
*Significant difference between hepatic glucuronide infusion and hepatic aglycone infusion, P<09.01
† Significant difference between hepatic aglycone infusion and small intestinal perfusion, P<0.01
‡ Not determined due to below quantification limit.
Appendix 2—table 5 after correction (corrected values highlighted for illustrative purposes in bold):
Appendix 2—table 5. Biliary glucuronide secretion rate and liver recycling efficiency of 16 different glucuronides.
| Infused compound (10 μM) | Secretion rate (nmol/hr)* | LRE%† |
|---|---|---|
| Ezetimibe-4'-G | 19.31±1.85 | 96.5±9.2 |
| Wogonin-7-G(wogonoside) | 16.3±4.28 | 81.5±21.4 |
| Raloxifene-4'-G | 11.48±2.32 | 57.4±11.6 |
| Apigenin-7-G | 10.64±4.49 | 53.2±22.4 |
| Raloxifene-6-G | 10.53±1.51 | 52.6±7.5 |
| Chrysin-7-G | 9.91±1.92 ‡ | 49.6±9.6 ‡ |
| Genestein-7-G | 9.45±3.21 ‡ | 47.3±16.0 ‡ |
| Icaritin-7-G | 7.46±0.72 | 37.3±3.6 |
| Icaritin-3-G | 5.35±1.12 | 26.8±5.6 |
| Scuttelarin | 4.34±1.18 | 21.7±5.9 |
| Biochanin A-G | 3.48±0.75 ‡ | 17.5±3.7 ‡ |
| Luteolin-3’-G | 1.33±0.34 | 6.7±1.7 |
| Baicalin | 0.69±0.30 | 3.4±1.5 |
| Luteolin-7-glycoside | 0.67±0.56 | 3.4±2.8 |
| Quercetin-3-G | 0.43±0.57 | 2.2±2.8 |
| Ace-G | 0.10±0.06 | 0.5±0.3 |
*The glucuronide secretion rate at the steady state was calculated by the linear regression of accumulated amount secreted in bile vs. time
†LRE (liver recycling efficiency) %=Excretion rate at steady state/infusion rate.
‡Data from previous published study [Zeng et al., 2016]
Appendix 2—table 5 before correction was provided as reference (original values highlighted for illustrative purposes in bold):
Appendix 2—table 5. Biliary glucuronide secretion rate and liver recycling efficiency of 16 different glucuronides.
| Infused compound (10 μM) | Secretion rate (nmol/hr)* | LRE%† |
|---|---|---|
| Ezetimibe-4'-G | 19.31±1.85 | 96.5±9.2 |
| Wogonin-7-G(wogonoside) | 16.3±4.28 | 81.5±21.4 |
| Genestein-7-G | 9.78 ‡ | 59.3 ‡ |
| Raloxifene-4'-G | 11.48±2.32 | 57.4±11.6 |
| Apigenin-7-G | 10.64±4.49 | 53.2±22.4 |
| Raloxifene-6-G | 10.53±1.51 | 52.6±7.5 |
| Chrysin-7-G | 9.86 ‡ | 49.3 ‡ |
| Icaritin-7-G | 7.46±0.72 | 37.3±3.6 |
| Biochanin A-G | 3.28 ‡ | 27.8 ‡ |
| Icaritin-3-G | 5.35±1.12 | 26.8±5.6 |
| Scuttelarin | 4.34±1.18 | 21.7±5.9 |
| Luteolin-3’-G | 1.33±0.34 | 6.7±1.7 |
| Baicalin | 0.69±0.30 | 3.4±1.5 |
| Luteolin-7-glycoside | 0.67±0.56 | 3.4±2.8 |
| Quercetin-3-G | 0.43±0.57 | 2.2±2.8 |
| Ace-G | 0.10±0.06 | 0.5±0.3 |
*The glucuronide secretion rate at the steady state was calculated by the linear regression of accumulated amount secreted in bile vs. time
†LRE (liver recycling efficiency) %=Excretion rate at steady state/infusion rate.
‡Data from previous published study [Zeng et al., 2016]
The article has been corrected accordingly.
Article and author information
Author details
Version history
Copyright
© 2022, Tu et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 139
- views
-
- 0
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Correction: Hepatoenteric recycling is a new disposition mechanism for orally administered phenolic drugs and phytochemicals in rats
eLife 11:e84431.
https://doi.org/10.7554/eLife.84431
